Elbreki et al., 2014 - Google Patents
Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatmentElbreki et al., 2014
View PDF- Document ID
- 6571362926893454773
- Author
- Elbreki M
- Ross R
- Hill C
- O′ Mahony J
- McAuliffe O
- Coffey A
- Publication year
- Publication venue
- Journal of Viruses
External Links
Snippet
The application of bacteriophages for the elimination of pathogenic bacteria has received significantly increased attention world‐wide in the past decade. This is borne out by the increasing prevalence of bacteriophage‐specific conferences highlighting significant and …
- 241001515965 unidentified phage 0 title abstract description 37
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/00041—Use of virus, viral particle or viral elements as a vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Elbreki et al. | Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatment | |
| Dy et al. | Phage-based biocontrol strategies and their application in agriculture and aquaculture | |
| Jamal et al. | Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields | |
| Rehman et al. | The dawn of phage therapy | |
| Dicks et al. | Bacteriophage–host interactions and the therapeutic potential of bacteriophages | |
| Drulis-Kawa et al. | Bacteriophages and phage-derived proteins–application approaches | |
| Golkar et al. | Bacteriophage therapy: a potential solution for the antibiotic resistance crisis | |
| Sarhan et al. | Phage approved in food, why not as a therapeutic? | |
| Drulis-Kawa et al. | Learning from bacteriophages-advantages and limitations of phage and phage-encoded protein applications | |
| Abedon | Phage therapy: eco‐physiological pharmacology | |
| Islam et al. | A systematic review from basics to omics on bacteriophage applications in poultry production and processing | |
| Oliveira et al. | Paving the way forward: Escherichia coli bacteriophages in a One Health approach | |
| Heselpoth et al. | Enzybiotics: endolysins and bacteriocins | |
| Sahu et al. | Bacteriophages concept and applications: A review on phage therapy | |
| Aprea et al. | The applications of bacteriophages and their lysins as biocontrol agents against the foodborne pathogens Listeria monocytogenes and Campylobacter: An updated look | |
| Rastogi et al. | An overview on bacteriophages: A natural nanostructured antibacterial agent | |
| Heselpoth et al. | Enzybiotics: endolysins and bacteriocins | |
| Wang et al. | Research progress on strategies for improving the enzyme properties of bacteriophage endolysins | |
| Nicastro et al. | Bacteriophage applications-historical perspective and future potential | |
| Moradpour et al. | Modified phages: novel antimicrobial agents to combat infectious diseases | |
| Nokhwal et al. | Bacteriophage therapy: an emerging paradigm in fish disease management | |
| Cui et al. | Next-generation antimicrobials: A review of phage lysins as precision weapons against drug-resistant pathogens | |
| Abdelrahman et al. | Phage-Encoded Endolysins. Antibiotics 2021, 10, 124 | |
| Gondil et al. | Clinical potential of bacteriophage and Endolysin based therapeutics: A futuristic approach | |
| Veiga-Crespo et al. | Advantages and disadvantages in the use of antibiotics or phages as therapeutic agents |